Related Experiment Video

Updated: Apr 27, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention

Claudio Pulito1, Toran Sanli2, Punam Rana3

  • 1Molecular Chemoprevention Group, Molecular Medicine Area, Regina Elena National Institute, Rome 00144, Italy. c.pulito@ifo.it.

Metabolites
|June 25, 2014
PubMed

Insights

Metformin, a diabetes drug, shows significant anticancer effects, suggesting metabolic reprogramming could prevent cancer. This research highlights its potential in cancer treatment and prevention strategies.

Area of Science:

  • Oncology
  • Metabolic Research
  • Pharmacology

Background:

  • Cancer metabolism is crucial in tumor development.
  • Metformin use in diabetic patients correlates with reduced cancer incidence and mortality.
  • Metabolic alterations are increasingly recognized as early events in cancer transformation.

Purpose of the Study:

  • To review the emerging role of metformin in cancer treatment.
  • To explore metformin's potential in cancer chemoprevention.
  • To highlight metabolic reprogramming as a public health strategy.

Main Methods:

  • Review of existing in vitro and in vivo studies on metformin's anticancer activities.
  • Analysis of clinical trial data involving metformin for cancer.
  • Examination of research on metformin's role in cancer chemoprevention.

Main Results:

  • Metformin demonstrates significant in vitro and in vivo anticancer activities.
  • Metformin is progressing into clinical trials for cancer treatment.
  • Metformin is a key focus in chemoprevention research, indicating metabolic alterations are early cancer lesions.

Conclusions:

  • Metabolic reprogramming is a promising strategy for cancer prevention.
  • Metformin serves as a prime example of repurposing existing drugs for cancer therapy.
  • Targeting metabolic alterations holds significant potential for public health impact in cancer control.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

12.4K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.6K

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
990
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
949